These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27089603)

  • 1. [Resting heart rate: how to use it for cardiovascular prevention?].
    Fassbind M; Yerly P; Nanchen D
    Rev Med Suisse; 2016 Mar; 12(508):454, 456-9. PubMed ID: 27089603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resting heart rate and cardiovascular disease].
    Brito Díaz B; Alemán Sánchez JJ; Cabrera de León A
    Med Clin (Barc); 2014 Jul; 143(1):34-8. PubMed ID: 23937816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate: a global target for cardiovascular disease and therapy along the cardiovascular disease continuum.
    Custodis F; Reil JC; Laufs U; Böhm M
    J Cardiol; 2013 Sep; 62(3):183-7. PubMed ID: 23806547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
    Böhm M; Reil JC; Deedwania P; Kim JB; Borer JS
    Am J Med; 2015 Mar; 128(3):219-28. PubMed ID: 25447617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta blockers and CVD protection; new frontriers.
    Chopra HK
    Indian Heart J; 2010; 62(2):98. PubMed ID: 21180296
    [No Abstract]   [Full Text] [Related]  

  • 6. Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information?
    Leistner DM; Klotsche J; Palm S; Pieper L; Stalla GK; Lehnert H; Silber S; März W; Wittchen HU; Zeiher AM;
    Eur J Prev Cardiol; 2012 Apr; 19(2):275-84. PubMed ID: 21450610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The resting heart rate].
    Bemelmans RH; Visseren FL
    Ned Tijdschr Geneeskd; 2014; 158():A6931. PubMed ID: 24666528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can reduction in resting heart rate be beneficial for patients?].
    Soucek M
    Vnitr Lek; 2007 Apr; 53(4):401-3. PubMed ID: 17578174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?
    Arnold JM; Fitchett DH; Howlett JG; Lonn EM; Tardif JC
    Can J Cardiol; 2008 May; 24 Suppl A(Suppl A):3A-8A. PubMed ID: 18437251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting heart rate in cardiovascular disease.
    Fox K; Borer JS; Camm AJ; Danchin N; Ferrari R; Lopez Sendon JL; Steg PG; Tardif JC; Tavazzi L; Tendera M;
    J Am Coll Cardiol; 2007 Aug; 50(9):823-30. PubMed ID: 17719466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resting pulse rate as an indicator of health and disease].
    Dalby M; Gjesdal K
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1348-51. PubMed ID: 22717860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated heart rate: a "new" cardiovascular risk factor?
    Palatini P
    Prog Cardiovasc Dis; 2009; 52(1):1-5. PubMed ID: 19615486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate as a treatable cardiovascular risk factor.
    Tardif JC
    Br Med Bull; 2009; 90():71-84. PubMed ID: 19474056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate and cardiovascular protection.
    Caetano J; Delgado Alves J
    Eur J Intern Med; 2015 May; 26(4):217-22. PubMed ID: 25704330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplifying cardiovascular risk estimation using resting heart rate.
    Cooney MT; Vartiainen E; Laatikainen T; Joulevi A; Dudina A; Graham I
    Eur Heart J; 2010 Sep; 31(17):2141-7. PubMed ID: 20657020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand?
    Menown IB; Davies S; Gupta S; Kalra PR; Lang CC; Morley C; Padmanabhan S
    Cardiovasc Ther; 2013 Aug; 31(4):215-23. PubMed ID: 22954325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated resting heart rate is associated with greater risk of cardiovascular and all-cause mortality in current and former smokers.
    Jensen MT; Marott JL; Jensen GB
    Int J Cardiol; 2011 Sep; 151(2):148-54. PubMed ID: 20605243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study.
    Jensen MT; Marott JL; Allin KH; Nordestgaard BG; Jensen GB
    Eur J Prev Cardiol; 2012 Feb; 19(1):102-8. PubMed ID: 21525123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.